Telbivudine for the treatment of chronic hepatitis B in HBeAg-positive patients in China: a health economic analysis.
about
P2860
Telbivudine for the treatment of chronic hepatitis B in HBeAg-positive patients in China: a health economic analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Telbivudine for the treatment ...... a: a health economic analysis.
@en
Telbivudine for the treatment ...... a: a health economic analysis.
@nl
type
label
Telbivudine for the treatment ...... a: a health economic analysis.
@en
Telbivudine for the treatment ...... a: a health economic analysis.
@nl
prefLabel
Telbivudine for the treatment ...... a: a health economic analysis.
@en
Telbivudine for the treatment ...... a: a health economic analysis.
@nl
P2093
P2860
P1433
P1476
Telbivudine for the treatment ...... a: a health economic analysis.
@en
P2093
P2860
P2888
P356
10.1186/S40064-016-3404-X
P50
P577
2016-10-05T00:00:00Z
P6179
1018675210